Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Increased Intracranial Pressure l: Introduction01:14

Increased Intracranial Pressure l: Introduction

Intracranial hypertension is a sustained elevation of intracranial pressure (ICP) above 22 mm Hg. In supine adults, normal ICP is ~7–15 mm Hg.The rigid, nonexpandable cranium contains three components—brain tissue, blood, and cerebrospinal fluid (CSF)—that total ~1,700 mL in a typical adult: 1,400 mL brain (~80%), 150 mL blood (~10%), and 150 mL CSF (~10%). According to the Monro–Kellie doctrine, total intracranial volume is effectively fixed. When one component expands, CSF and venous blood...
Ophthalmic Drug Delivery Systems01:23

Ophthalmic Drug Delivery Systems

Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The physical spacing between the von Willebrand factor D'D3 and A1 domains regulates platelet adhesion in vitro and in vivo.

Journal of thrombosis and haemostasis : JTH·2017
Same author

Psychiatric disorders in children with temporal lobe epilepsy: a controlled investigation.

Indian journal of psychiatry·2011
Same author

Koro-like syndrome: a case report.

Indian journal of psychiatry·2011
Same author

Fluphenazine decanoate in chronic schizophrenia.

Indian journal of psychiatry·2011
Same author

Pre-operative anxiety and its management in dentistry.

Indian journal of psychiatry·2011
Same author

Serum potassium changes with e.C.T.

Indian journal of psychiatry·2011
Same journal

Exploring the relationship between snake bites and post-traumatic stress disorder: A prospective study on associated factors.

Indian journal of psychiatry·2026
Same journal

Non-invasive brain stimulation as an experimental treatment approach for bulimia nervosa and binge eating disorders: A meta-analysis and systematic review of literature.

Indian journal of psychiatry·2026
Same journal

Re-examining the severity classification utility of the Indian scale for assessment of autism in children with autism having co-morbid conditions.

Indian journal of psychiatry·2026
Same journal

How clinicians think about dual disorders: Insights from a case vignette survey.

Indian journal of psychiatry·2026
Same journal

Teaching and shaping young minds: Perspectives of south Indian medical students on psychiatry education- An online survey.

Indian journal of psychiatry·2026
Same journal

Cognitive and emotional empathy in schizophrenia as State-independent impairment: A multidimensional task paradigm study.

Indian journal of psychiatry·2026
See all related articles

Related Experiment Video

Updated: May 27, 2026

Trabecular Meshwork Response to Pressure Elevation in the Living Human Eye
09:03

Trabecular Meshwork Response to Pressure Elevation in the Living Human Eye

Published on: June 20, 2015

Intraocular pressure changes following modified e.C.T.

G D Shukla1, U C Sharma, A N Mehrotra

  • 1Lecturer in Psychiatry, M.L.B. Medical College, Jhansi (U.P.).

Indian Journal of Psychiatry
|November 8, 2011
PubMed
Summary
This summary is machine-generated.

Modified electroconvulsive therapy (ECT) increases intraocular pressure. Succinylcholine exacerbates this rise, causing a more significant and prolonged elevation in eye pressure during the procedure.

More Related Videos

Translaminar Autonomous System Model for the Modulation of Intraocular and Intracranial Pressure in Human Donor Posterior Segments
08:55

Translaminar Autonomous System Model for the Modulation of Intraocular and Intracranial Pressure in Human Donor Posterior Segments

Published on: April 24, 2020

Related Experiment Videos

Last Updated: May 27, 2026

Trabecular Meshwork Response to Pressure Elevation in the Living Human Eye
09:03

Trabecular Meshwork Response to Pressure Elevation in the Living Human Eye

Published on: June 20, 2015

Translaminar Autonomous System Model for the Modulation of Intraocular and Intracranial Pressure in Human Donor Posterior Segments
08:55

Translaminar Autonomous System Model for the Modulation of Intraocular and Intracranial Pressure in Human Donor Posterior Segments

Published on: April 24, 2020

Area of Science:

  • Anesthesiology
  • Ophthalmology
  • Neurology

Background:

  • Electroconvulsive therapy (ECT) is a medical treatment.
  • Understanding its physiological effects, such as on intraocular pressure (IOP), is crucial for patient safety.
  • The role of muscle relaxants like succinylcholine in modifying these effects requires investigation.

Purpose of the Study:

  • To investigate and compare intraocular pressure changes during modified ECT.
  • To determine the specific impact of succinylcholine administration on IOP during modified ECT.

Main Methods:

  • A study was conducted involving sixty cases undergoing modified ECT.
  • Intraocular pressure was monitored in two groups: those receiving modified ECT with succinylcholine and those without.
  • Changes in IOP were recorded and analyzed.

Main Results:

  • Intraocular pressure increased in both groups undergoing modified ECT.
  • The rise in IOP was more pronounced and lasted longer in the group that received succinylcholine.
  • This indicates a significant effect of succinylcholine on IOP during ECT.

Conclusions:

  • Modified ECT is associated with an increase in intraocular pressure.
  • Succinylcholine administration during modified ECT leads to a more substantial and sustained elevation of IOP.
  • Anesthesiologists and clinicians should consider these findings when managing patients undergoing ECT, particularly those with pre-existing ocular conditions.